If you are over 45, you probably know the routine. You hold your phone at arm’s length. You squint at restaurant menus. You dig through bags and drawers looking for reading glasses you swore were right there a minute ago. Age-related blurry near vision, called presbyopia, affects roughly 128 million adults in the United States alone. For most people, the fix has been simple: grab a pair of readers and accept that your eyes are not what they used to be. But a newly approved prescription eye drop is offering a different option. One drop per day, and many adults can see clearly up close for up to 10 hours without reaching for glasses. It is not a cure for aging eyes. But for millions of people frustrated by the daily hassle of reading glasses, it could change how they get through the day.
What Presbyopia Actually Does to Your Eyes
Presbyopia is not a disease. It is a natural part of aging that catches up with nearly everyone. Starting in your mid-40s, the crystalline lens inside your eye gradually hardens and loses its ability to change shape. That flexibility is what allows your eye to shift focus between distant and nearby objects.
As the lens stiffens, it can no longer bend enough to focus incoming light from close-up objects onto your retina. Words on a page blur. Screens become harder to read. Fine print becomes nearly impossible without help.
Presbyopia progresses over time. Adults over 50 lose, on average, 1.5 lines of near vision every six years. While the decline is gradual, many people experience a sudden moment in their mid-40s when they realize they can no longer read a text message or a label without holding it further away. That moment sends millions of people to the drugstore for their first pair of reading glasses.
Until recently, the options for managing presbyopia were limited to glasses, contact lenses, or surgery. Each comes with tradeoffs in convenience, comfort, cost, and appearance. For people who have never worn glasses before, the adjustment can feel frustrating.
Vizz: A New Kind of Eye Drop
In July 2025, the FDA approved Vizz (aceclidine ophthalmic solution) 1.44%, the first aceclidine-based eye drop approved in the United States for treating presbyopia in adults. Developed by Lenz Therapeutics, Vizz is a once-daily, preservative-free drop delivered in single-use vials.
Aceclidine, the active ingredient, works differently from the eye drops that came before it. It is what scientists call a predominantly pupil-selective miotic. In plain language, it causes the iris sphincter muscle to contract, creating a “pinhole effect” that extends your eye’s depth of focus. Think of it like narrowing the aperture on a camera lens: a smaller opening allows a wider range of distances to stay in focus at the same time.
What makes Vizz different from earlier presbyopia drops is how tightly it constricts the pupil. Vizz achieves a sub-2mm pupil size, which provides a stronger near vision improvement without causing a myopic shift (an unwanted change in distance vision).
Daniel Diamond, an assistant professor of optometric science at Columbia University, noted that drops are a good option for people who cannot use glasses or contact lenses, or who do not want the burden of carrying separate pairs for distance and reading correction.
How Fast It Works and How Long It Lasts
FDA approval was based on results from three Phase 3 clinical trials involving nearly 700 participants. In the two main trials (CLARITY 1 and CLARITY 2), people with presbyopia received either Vizz or placebo drops once daily for 42 days. A third trial (CLARITY 3) tracked 217 participants for six months to evaluate long-term safety.
Vizz improved near vision within 30 minutes of application. The effect lasted for up to 10 hours, making it the longest-acting once-daily presbyopia drop currently available.
Both primary and secondary endpoints for near vision improvement were met in CLARITY 1 and 2. Results were consistent and reproducible across both trials. Across more than 30,000 treatment days in all three studies, no serious treatment-related side effects were reported.
Common side effects were mild, temporary, and resolved on their own. About 20% of participants experienced brief irritation at the site where the drop was applied. Roughly 16% noticed temporary dim vision. About 13% reported headaches. Some participants had mild eye redness.
How Vizz Compares to Other Presbyopia Drops
Vizz is not the first eye drop approved for presbyopia, but it may be the most effective option available. Two older products, Vuity and Qlosi, both use a different active ingredient called pilocarpine hydrochloride. Like aceclidine, pilocarpine works by causing eye muscles to contract, but the results differ in duration and pupil response.
Vuity, made by AbbVie, is approved for once or twice daily use. In clinical trials testing twice-daily application, it improved near vision for up to nine hours. Qlosi, made by Orasis Pharmaceuticals, lasts up to eight hours.
Eric Donnenfeld, a clinical professor of ophthalmology at New York University, explained the practical difference: from a patient perspective, Vizz lasts longer and produces a smaller pupil, providing better near vision than previous-generation medications.
Because Vizz achieves a tighter pupil constriction, it creates a sharper pinhole effect and a broader depth of focus. For patients, that translates to clearer near vision with fewer visual disturbances during the day.
What to Watch Out For
Vizz is not without downsides. Sidney Gicheru, an ophthalmologist and clinical spokesperson for the American Academy of Ophthalmology, pointed out that the drops have a limited period of effectiveness. While FDA-approved as a once-daily medication, the prescribing information indicates the effect may not last a full day for everyone.
Night vision is another consideration. Because Vizz constricts the pupil, it reduces the amount of light entering the eye in dim conditions. People who drive at night or work in low-light environments should be aware that the drops can affect how well they see in the dark.
Temporary dim or dark vision may occur after application. Lenz Therapeutics advises not driving or operating machinery if vision is not clear. Contact lens wearers should remove lenses before applying the drop and wait at least 10 minutes before reinserting them. Anyone experiencing sudden flashing lights, floaters, or vision loss after using the drops should seek immediate medical care.
Who Should Consider Eye Drops Over Glasses
For most people with presbyopia, reading glasses remain a perfectly effective and affordable solution. Diamond, from Columbia, noted that the vast majority of his patients in their early forties do well with reading glasses.
But drops fill a gap for specific groups of people. Those who have never worn glasses and resist starting may find drops more appealing than frames. People who work in environments where glasses are impractical, such as operating rooms, construction sites, or athletic fields, could benefit from a lens-free option. Anyone who dislikes the appearance of reading glasses or the inconvenience of switching between distance and reading pairs may prefer a daily drop.
Cost is a factor. Vizz may run around $80 per month with insurance, according to Donnenfeld. Without insurance, the price could be higher. Comparing that monthly expense to the one-time purchase of reading glasses or the cost of multifocal contact lenses will help individuals decide which option fits their budget and lifestyle.
Vizz became available for sampling by healthcare providers starting in October 2025, with broad commercial availability expected by the end of the year.
A Growing Market With More Options Ahead
Presbyopia affects an estimated 1.8 billion people globally. As populations age, that number will continue to rise. The market for convenient, non-surgical treatments is growing, and pharmaceutical companies are investing heavily in new solutions.
Vizz represents the latest step in a shift that began with Vuity’s approval in 2021: moving presbyopia management from the optical shop to the pharmacy. While glasses and contacts are not going anywhere, having a prescription eye drop that delivers 10 hours of improved near vision gives patients and doctors another tool in the toolkit.
For the millions of adults who have been holding their phones further and further away, that extra option may be exactly what they have been squinting for.
My Personal RX on Seeing the Big Picture in Your 40s and Beyond
As we reach our 40s and 50s, the sudden need to hold a menu at arm’s length or rely on prescription eye drops is often one of the first undeniable signs that our bodies are changing. While it can be frustrating to suddenly struggle with fine print, I always encourage my patients to view these shifts as a valuable wake-up call. Your eyes are a direct window into your vascular and neurological health, and the onset of presbyopia is a natural reminder that it is time to be more intentional about how we care for ourselves.
Medical innovations like daily eye drops offer fantastic convenience, but addressing the symptoms of aging is only part of the equation. True vitality requires a proactive approach that supports your vision, your brain, and your entire body from the inside out. Here are my personal tips to help you protect your eyesight and optimize your overall well-being as you navigate this new chapter.
- Practice the 20-20-20 Rule: Constant screen time accelerates eye fatigue and strain, exacerbating the blurriness you might already be feeling. Every 20 minutes, take a break to look at something at least 20 feet away for 20 seconds to give your eye muscles a necessary rest.
- Prioritize Targeted Vision Support: As the crystalline lens in your eye stiffens, ensuring optimal blood flow and nutrient delivery to the eye becomes critical. I recommend incorporating Eye Max to provide targeted support for macular health and ocular circulation, keeping your vision as sharp and resilient as possible.
- Fill the Age-Related Nutrient Gaps: The same biological shifts that change your eyesight also impact how your body absorbs vital nutrients. To keep your energy, digestion, and stress response steady and supported, consider the Core Four Bundle. It combines Omega-3 Fish Oil, Ultra Cal-Mag, Vitamin D3 + K2, and MindBiotic to help fill the most common nutrient gaps that start to show up after 40 and give your body what it needs to function well now and stay strong over time.
- Eat for Your Eyes: Your diet plays a massive role in combating oxidative stress. Incorporate plenty of dark leafy greens, colorful berries, and healthy fats into your meals to provide the lutein, zeaxanthin, and antioxidants your eyes need to thrive.
- Hydrate for Ocular Moisture: As we age, tear production naturally decreases, which can make focusing even harder and cause irritation. Drinking plenty of water throughout the day ensures your eyes stay lubricated and comfortable.
- Adopt a Comprehensive Wellness Strategy: Changing eyesight is the perfect gentle nudge to re-evaluate your overall daily habits. If you want to build a better foundation, Dr. Partha Nandi’s Protocol For Optimizing Your Health & Wellbeing is a powerful and comprehensive guide to living your best life by focusing on holistic health, from your gut to your brain.
- Wear UV Protection Year-Round: Cumulative sun exposure can damage the retina and accelerate the development of cataracts. Always wear sunglasses with 100% UVA and UVB protection when outdoors, even on cloudy days.
- Optimize Your Screen Environment: Make technology work for your changing vision, not against it. Increase the default font size on your phone and computer, and ensure your workspace is well-lit to prevent your pupils from overworking in dim lighting.
- Prioritize Restorative Sleep: Your eyes rely on deep, uninterrupted sleep to clear out daily irritants and repair cellular damage. Aim for 7 to 8 hours of quality sleep a night to wake up with refreshed, focused vision.
- Schedule Comprehensive Eye Exams: Whether you rely on glasses, contacts, or new prescription drops, do not skip your annual visit to the eye doctor. Dilated eye exams are crucial for catching silent, age-related conditions like glaucoma or macular degeneration long before they affect your vision.
Source:
- Aslam, H. G., Fatima, M., Sajid, H., Irshad, N. U. N., & Imran, S. B. (2025). FDA approval of aceclidine (Vizz): a new chapter in nonsurgical presbyopia management. Annals of Medicine and Surgery, 87(11), 6967β6969. https://doi.org/10.1097/ms9.0000000000004008
